3:18cv1647 • July 19, 2018
Class Period Start
April 29, 2016
Class Period End
July 9, 2018
PSLRA Deadline
September 17, 2018
Case Allegations
10b5
Statutes of Repose
Apr 29, 2019
Country
United States
Court
Federal Court
Feb 4, 2022
Jan 3, 2022
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
May 31, 2021
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Apr 20, 2021
Apr 16, 2021
A new complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Mar 29, 2021
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Dec 30, 2020
Aug 28, 2020
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Jul 27, 2020
Jul 20, 2020
Jul 16, 2020
A new complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Jul 9, 2020
Jun 30, 2020
Jun 1, 2020
Motion to Dismiss Denied in Part
The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.
Aug 23, 2019
Jun 7, 2019
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
May 29, 2019
Apr 15, 2019
A new complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Mar 7, 2019
Feb 26, 2019
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Sep 18, 2018
Jul 23, 2018
Another plaintiff has filed a complaint on behalf of investors in ACADIA PHARMACEUTICALS INC. The allegations and class definitions are substantively the same.
Jul 19, 2018
A securities fraud class action complaint has been filed on behalf of certain investors in ACADIA PHARMACEUTICALS INC.
TOP
